Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemot

Discussion Board › Forums › Radiation Treatments & Options › Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemot

Viewing 4 posts - 1 through 4 (of 4 total)
  • Author
    Posts
  • August 5, 2015 at 5:24 am #89084
    johnkristie
    Member

    Thank you for clearing that up. It’s hard to understand what went on in some of these studies. The good news is it will give our loved ones more time than they had before:)

    July 31, 2015 at 2:13 am #89083
    marions
    Moderator

    middlesister….The median survival is measured at a time when more than 50% of patient have survived. The ABC study, comparing gemcis/vs. gem alone noted a medium survival of 11.7 months among the 204 patients in the cisplatin-gemcitabine group and 8.1 months among the 206 patients in the gemcitabine group.
    The http://www.ncbi.nlm.nih.gov/pubmed/26204219 study did not look for statistical data measuring median Overall Survival (OS) after the SIRT treatment. This study’s endpoints are progression-free survival (PFS) and overall survival (OS) only.
    Hugs
    Marion

    July 31, 2015 at 12:42 am #89082
    middlesister1
    Moderator

    Thanks Gavin. I’ll have to follow up on this one to get the full article I think OS not reached is a good thing :)

    July 25, 2015 at 5:26 pm #11536
    gavin
    Moderator

    Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma.

    http://www.ncbi.nlm.nih.gov/pubmed/26204219

  • Author
    Posts
Viewing 4 posts - 1 through 4 (of 4 total)
  • The forum ‘Radiation Treatments & Options’ is closed to new topics and replies.